IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+13.9%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$284M
AUM Growth
+$284M
(+10%)
Cap. Flow
+$34.2M
Cap. Flow
% of AUM
12.07%
Top 10 Holdings %
Top 10 Hldgs %
45.99%
Holding
71
New
15
Increased
14
Reduced
11
Closed
6
Top Buys
| 1 |
Nektar Therapeutics
NKTR
|
$12.6M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$5.68M |
| 3 |
SHPG
Shire pic
SHPG
|
$4.84M |
| 4 |
STML
Stemline Therapeutics, Inc.
STML
|
$4.84M |
| 5 |
Exelixis
EXEL
|
$4.74M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$5.75M |
| 2 |
Sarepta Therapeutics
SRPT
|
$5.23M |
| 3 |
CALA
Calithera Biosciences, Inc
CALA
|
$2.95M |
| 4 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$2.54M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$2.36M |
Sector Composition
| 1 | Healthcare | 91.95% |
